
Advances in CAR-T and cellular therapy from EBMT 2020: MSCs, clinical trial updates and gene-edited effector cells
VJHemOnc Podcast
Introduction
Experts discuss recent updates in CAR-T and cellular therapy, including T cell engineering, CRISPR gene disruption, and the use of mesenchymal stem cells for graft versus host disease and COVID-19 inflammatory disease.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.